Merck in Talks to Buy Revolution Medicines for Around $30 Billion

Merck

MRK

decrease; red down pointing triangle is in talks to acquire Revolution Medicines

RVMD 10.48%

increase; green up pointing triangle in a deal that could value it at around $30 billion, according to people familiar with the matter. 

A deal for the cancer-drug biotech could come as soon as later this month, the people said, cautioning the talks could still fall apart or another suitor could prevail.